(Q43070999)

13 November 2017

1 reference

title

Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations (English)

1 reference

13 November 2017

0 references

Eisenstein TK

1

1 reference

PubMed ID

9610671

13 November 2017

Hilburger ME

series ordinal

2

1 reference

13 November 2017

1 March 1998

1 reference

Journal of Neuroimmunology

13 November 2017

1 reference

13 November 2017

83

1 reference

13 November 2017

36-44

1 reference

13 November 2017

1-2

1 reference

The opioid system and temperature regulation

13 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Morphine-induced immune alterations in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Sequence of kappa-opioid receptor cDNA in the R1.1 thymoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Detection of kappa-opioid receptor mRNA in immature T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Effects of morphine tolerance and abstinence on cellular immune function.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Influence of morphine and naloxone on human peripheral blood T-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Immunosuppressive effects of chronic morphine treatment in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Differential effects of morphine and naltrexone on the antibody response in various mouse strains

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Effects of in vivo morphine treatment on antibody responses in C57BL/6 bgJ/bgJ (beige) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Chronic morphine treatment suppresses CTL-mediated cytolysis, granulation, and cAMP responses to alloantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Pretreatment with beta-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Enantioselective kappa opioid binding sites on the macrophage cell line, P388d1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Central alpha-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Inhibition by opioids of phagocytosis in peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Evidence for an inhibitory role of β-endorphin and other opioids on human total T rosette formation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T-cell E-rosette formation and antigenic marker expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Mechanistic implications of the findings that opiates and other drugs of abuse moderate T-cell surface receptors and antigenic markers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Comparative effects of morphine on leukocytic antigenic markers of monkeys and humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

The effect of morphine and DAGO on the proliferative response of murine splenocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Dynorphin and related opioid peptides enhance tumoricidal activity mediated by murine peritoneal macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Both T cells and macrophages are targets of kappa-opioid-induced immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Augmenting effect of opioid peptides on murine macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

The effect of morphine addiction on concanavalin A-mediated blastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Regulation of the in vitro antibody response by neuroendocrine hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Differential processing of proenkephalin-A by human peripheral blood monocytes and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Identification of kappa opioid receptors in the immune system by indirect immunofluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Effects of certain abused drugs on hemolysin forming cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Binding of naloxone to human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Peptide opioids and morphine effects on inflammatory process

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Opiate receptors on lymphocytes and platelets in man

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (mu-, kappa-, and delta-) selective agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Regulation of human natural cytotoxicity by enkephalins and selective opiate agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Characterization of opiate binding sites on membranes of rat lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Classification of opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Suppression of the induction of delayed hypersensitivity in rats by repetitive morphine treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Opioids depress in vitro human monocyte chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Suppression of human peripheral blood mononuclear cell function by methadone and morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Enhancement of human natural killer cell activity by opioid peptides: similar response to methionine-enkephalin and beta-endorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Opioid receptor-mediated suppression of humoral immune response in vivo and in vitro: involvement of kappa opioid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

[3H]morphine binding is enhanced by IL-1-stimulated thymocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Opiate receptor-mediated chemotaxis of human monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Involvement of brain opiate receptors in the immune-suppressive effect of morphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Opioid peptides and opioid receptors in cells of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

[D-Ala2]deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Immunomodulatory activity of mu- and kappa-selective opioid agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Immunomodulatory effects of in vitro exposure to morphine and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Direct cellular immunomodulation produced by diacetylmorphine (heroin) or methadone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Effect of Morphine on Resistance to Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

The periaqueductal gray matter mediates opiate-induced immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900219-1

7 January 2021

10.1016/S0165-5728(97)00219-1

Identifiers

DOI

1 reference

13 November 2017

1 reference

PubMed ID

9610671